Skip to main content
Novartis
language-selector-globe
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Andean & CAC | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
Ukraine | українська
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Andean & CAC | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
Ukraine | українська
United Kingdom | English
United States | English
    • About 
      • Novartis in Ireland 
      • Country Leadership Team 
      • Contact 
      Novartis office
      About
    • Patients and Caregivers 
      • Novartis Commitment to Patients and Caregivers 
      • Education and Awareness 
      • Patient Resources 
      • Adverse Event Reporting 
      • Novartis Societal Impact 
      Happy family outdoors
      Patients and Caregivers
    • Healthcare Professionals 
      • Healthcare professional country resource 
      • Adverse Event Reporting 
      • Novartis Clinical Trials 
      • Novartis Ireland travel and Expenses Guidance 
      Healthcare professional talking with patient.
      Healthcare Professionals
    • ESG 
      • Ethical Behavior 
        • Code of Ethics 
        • SpeakUp 
      • Ethics, Risk and Compliance 
      • Environmental Sustainability 
      As a global company, Novartis has a great responsibility and an even greater opportunity to lead the world in creating a positive social change, embracing societal impact as a core business objective.
      ESG
    • News 
      • News Archive 
      • Stories 
      • Contacts 
      Working on a Tablet
      News
    • Careers 
      • Career Search 
      • Working in Novartis Ireland 
      • Learning and Development 
      • Early Talent 
      • How We Work 
      • Well-being 
      • Diversity & Inclusion 
      • Awards and Recognition 
      Careers
      Careers
    • Investors
      • Financial Data 
    • Coronavirus 
      covid 10 grey image_0_0
      Coronavirus
    Home

Stories

Story Navigation
  • All Topics
  • Education & Awareness
  • Corporate
  • People and Culture
icon
  • Group photo on World MS Day
    Education Awareness
    Mar 17, 2022

    A Recent Survey Shows that 44% of Irish People have Poor Understanding of the Symptoms and Nature of Multiple Sclerosis (MS)

    A survey commissioned by MS Ireland and Novartis Ireland to mark World MS Day 2019 explores the public’s awareness of the visible and invisible symptoms of MS.

    Education Awareness
  • Michael Lyster Heart Failure Irish Heart Foundation
    Education Awareness
    Mar 17, 2022

    Don't Ignore the Signs of Heart Failure, Warns Michael Lyster

    Education Awareness
  • Group photo at the launch of MS Explored
    Education Awareness
    Mar 17, 2022

    MS Explored Meeting

    Education Awareness
  • compact_imaging_eye_diseases_AMD_diabetic_retinopathy_age-related_macular_degeneration
    Corporate
    Mar 17, 2022

    Novartis Signs Collaboration Agreement to Fund Medtech Development of Low Cost Eye Monitor

    Corporate
  • European_Patient_Innovation_Summit_2018
    Education Awareness
    Mar 17, 2022

    European Patient Innovation Summit 2018

    Education Awareness
  • AMD_Awareness_Week_2018_Deirdre_O'Kane
    Education Awareness
    Mar 17, 2022

    Deirdre O’Kane Launches AMD Awareness Week

    Education Awareness
  • Novartis_Headway_Volunteers_Community_Partnership_Day_CPD
    People and Culture
    Mar 17, 2022

    Novartis Ireland’s 22nd Annual Community Partnership Day

    People and Culture
  • Galway_Mayor_International_Heart_Hub_iHHUB_Croi
    Education Awareness
    Mar 17, 2022

    Galway, Cork and Dublin - Amongst the First European Cities to Launch Global Campaign

    Education Awareness
  • Show_Some_Heart_Temporary_Tattoos
    Education Awareness
    Mar 17, 2022

    Novartis Supports Irish Heart Foundation's Show Some Heart Campaign

    Education Awareness
  • Brain_Conference_Poster_Image
    Education Awareness
    Mar 17, 2022

    Neurological Alliance of Ireland and Irish Brain Council Conference

    Education Awareness
  • Heart_Failure_Image_1
    Education Awareness
    Mar 17, 2022

    Irish Heart Foundation and Michael Lyster Team Up to Draw Attention to the Warning Signs of Heart Failure

    Education Awareness
  • Dublin_Hub_for_European_Patient_Innovation_Summit_Image
    Education Awareness
    Mar 17, 2022

    Dublin Hub for European Patient Innovation Summit

    Patient groups from all over Europe participated in the 2nd annual European Patient Innovation Summit (EPIS 2017), supported by Novartis.

    Education Awareness

Pagination

  • ‹ Previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • › Next page

Novartis Ireland

Navigate Novartis
  • Patients and Caregivers
  • Healthcare Professionals
  • ESG
  • News
  • Careers
Media Center
  • News Archive
  • Stories
Other Novartis Websites
  • Healthcare Professional Resources
  • Global site
Footer Bottom
© 2025 Novartis AG
  • Privacy Policy
  • Terms of Use
  • Cookie Settings
  • Site Map
  • Web Accessibility
Novartis Site Directory
Site intended for audiences in Ireland IE417033 March 24